As a specific inhibitor of TLR4, the benefit of TAK242 against histological kidney damage indicates a potential role of TLR4 in burn-induced AKI, while the effect of the NF-κB inhibitor PDTC suggests a pivotal role of NF-κB. The gene discussed is NFKB1; the disease is Nephropathy.